Stelios Papadopoulos - 30 Nov 2021 Form 4 Insider Report for Regulus Therapeutics Inc. (RGLS)

Role
Director
Signature
Christopher Aker, Attorney in Fact
Issuer symbol
RGLS
Transactions as of
30 Nov 2021
Net transactions value
+$800,000
Form type
4
Filing time
01 Dec 2021, 15:12:11 UTC
Previous filing
02 Jul 2021
Next filing
24 Feb 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGLS Common Stock Award $800,000 +2,222,222 +78% $0.3600 5,061,929 30 Nov 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.